Regeneron Pharmaceuticals Inc. buy mnake
Summary
This prediction ended on 04.01.18 with a price of €324.00. The price of Regeneron Pharmaceuticals Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -24.78%. mnake has 50% into this predictionRegeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
Performance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Regeneron Pharmaceuticals Inc. | 2.850% | 2.850% | 35.084% | 113.345% |
iShares Core DAX® | -1.189% | -3.063% | 10.586% | 15.272% |
iShares Nasdaq 100 | 3.663% | 8.732% | 34.914% | 58.325% |
iShares Nikkei 225® | -1.422% | -0.414% | 3.883% | 4.190% |
iShares S&P 500 | 2.182% | 4.907% | 28.279% | 51.241% |
Comments by mnake for this prediction
In the thread Regeneron Pharmaceuticals Inc. diskutieren
nur eine temporäre Schwäche
ich sehe bei Regeneron nur eine temporäre Schwäche, der Kurs sollte mittelfristig wieder anziehen, Langfristig sehe ich den Wert eh höher. die news der letzten Wochen lassen das zu.
Stopped prediction by mnake for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
17.01.17
09.03.17
09.03.17
Regeneron Pharmaceuticals Inc.
11.03.16
01.08.16
01.08.16
Regeneron Pharmaceuticals Inc.
15.12.14
20.01.15
20.01.15